Discontinuation report TRIZIVIR

Last updated on 2019-09-18 History
Report ID 94278
Drug Identification Number 02244757
Brand name TRIZIVIR
Common or Proper name abacavir (as abacavir sulfate), lamivudine and zidovudine tablets
Company Name VIIV HEALTHCARE ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ZIDOVUDINE ABACAVIR LAMIVUDINE
Strength(s) 300MG 300MG 150MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60's
ATC code J05AR
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-09-17
Remaining supply date 2020-06-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-877-393-8448

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2019-09-18 French Compare
v1 2019-09-18 English Compare

Showing 1 to 2 of 2